Zobrazeno 1 - 2
of 2
pro vyhledávání: '"White, H. D. (Harvey D.)"'
Autor:
Bittner, V. A. (Vera A.), Szarek, M. (Michael), Aylward, P. E. (Philip E.), Bhatt, D. L. (Deepak L.), Diaz, R. (Rafael), Edelberg, J. M. (Jay M.), Fras, Z. (Zlatko), Goodman, S. G. (Shaun G.), Halvorsen, S. (Sigrun), Hanotin, C. (Corinne), Harrington, R. A. (Robert A.), Jukema, W. (Wouter), Loizeau, V. (Virginie), Moriarty, P. M. (Patrick M.), Moryusef, A. (Angèle), Pordy, R. (Robert), Roe, M. T. (Matthew T.), Sinnaeve, P. (Peter), Tsimikas, S. (Sotirios), Vogel, R. (Robert), White, H. D. (Harvey D.), Zahger, D. (Doron), Zeiher, A. M. (Andreas M.), Steg, G. (Gabriel), Schwartz, G. G. (Gregory G.), Huikuri, H. (Heikki)
Background: Lipoprotein(a) concentration is associated with cardiovascular events. Alirocumab, a proprotein convertase subtilisin/kexin type 9 inhibitor, lowers lipoprotein(a) and low-density lipoprotein cholesterol (LDL-C). Objectives: A pre-specifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::0a92a36434f57e32a31ea84b5af3336c
http://urn.fi/urn:nbn:fi-fe2021102151986
http://urn.fi/urn:nbn:fi-fe2021102151986
Autor:
Nauck, M. A. (Michael A.), McGuire, D. K. (Darren K.), Pieper, K. S. (Karen S.), Lokhnygina, Y. (Yuliya), Strandberg, T. E. (Timo E.), Riefflin, A. (Axel), Delibasi, T. (Tuncay), Peterson, E. D. (Eric D.), White, H. D. (Harvey D.), Scott, R. (Russell), Holman, R. R. (Rury R.)
Background: To examine the effects of the DPP-4i sitagliptin on CV outcomes during and after incident MI in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). Methods: TECOS randomized 14,671 participants with type 2 diabetes and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::800b9ef7f2f60ee36fe7c5a1abbae8d7
http://urn.fi/urn:nbn:fi-fe2020040710670
http://urn.fi/urn:nbn:fi-fe2020040710670